Efficacy and prognosis of robotic surgery with sentinel node navigation surgery in endometrial cancer
Journal of Gynecologic Oncology · 2023
DOI: 10.3802/jgo.2023.34.e68 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gynecologic Oncology, 2023. Verfasst von Shinichi Togami und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Faculty of Medicine, Kagoshima University, Kagoshima, Japan. Hauptthemen laut MEDLINE: Sentinel Lymph Node, Robotic Surgical Procedures, Lymphocele, Endometrial Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
OBJECTIVE: This study aimed to validate the surgical and oncologic outcomes of robotic surgery with sentinel node navigation surgery (SNNS) in endometrial cancer. METHODS: This study included 130 patients with endometrial cancer, who underwent robotic surgery, including hysterectomy, bilateral salpingo-oophorectomy, and pelvic SNNS at the Department of Obstetrics and Gynecology of Kagoshima University Hospital. Pelvic sentinel lymph nodes (SLNs) were identified using the uterine cervix 99m Technetium-labeled phytate and indocyanine green injections. Surgery-related and survival outcomes were also evaluated. RESULTS: The median operative and console times and volume of blood loss were 204 (range: 101-555) minutes, 152 (range: 70-453) minutes, and 20 (range: 2-620) mL, respectively. The bilateral and unilateral pelvic SLN detection rates were 90.0% (117/130) and 5.4% (7/130), respectively, and the identification rate (the rate at which at least one SLN could be identified on either side) was 95% (124/130). Lower extremity lymphedema occurred in only 1 patient (0.8%), and no pelvic lymphocele occurred. Recurrence occurred in 3 patients (2.3%), and the recurrence site was the abdominal cavity, with dissemination in 2 patients and vaginal stump in one. The 3-year recurrence-free survival and 3-year overall survival rates were 97.1% and 98.9%, respectively. CONCLUSION: Robotic surgery with SNNS for endometrial cancer showed a high SLN identification rate, low occurrence rates of lower extremity lymphedema and pelvic lymphocele, and excellent oncologic outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Faculty of Medicine, Kagoshima University, Kagoshima, Japan.
- Department of Obstetrics and Gynecology, Faculty of Medicine, Kagoshima University, Kagoshima, Japan. hirokoba@m2.kufm.kagoshima-u.ac.jp.
ORCID-Profile: Shinichi Togami, Mika Fukuda, Mika Mizuno, Shintaro Yanazume, Hiroaki Kobayashi
Zitieren
APA
Togami, S., Fukuda, M., Mizuno, M., Yanazume, S., & Kobayashi, H. (2023). Efficacy and prognosis of robotic surgery with sentinel node navigation surgery in endometrial cancer. Journal of Gynecologic Oncology. https://doi.org/10.3802/jgo.2023.34.e68
Vancouver
Togami S, Fukuda M, Mizuno M, Yanazume S, Kobayashi H. Efficacy and prognosis of robotic surgery with sentinel node navigation surgery in endometrial cancer. Journal of Gynecologic Oncology. 2023. doi:10.3802/jgo.2023.34.e68
BibTeX
@article{Togami2023,
author = {Togami, Shinichi and Fukuda, Mika and Mizuno, Mika and Yanazume, Shintaro and Kobayashi, Hiroaki},
title = {Efficacy and prognosis of robotic surgery with sentinel node navigation surgery in endometrial cancer},
journal = {Journal of Gynecologic Oncology},
year = {2023},
doi = {10.3802/jgo.2023.34.e68}
}
EUVIMED